Clinical Trial

Study of the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Netakimab in Children With Moderate to Severe Plaque Psoriasis

Study acronym: PLANETA-KIDS
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to evaluate the efficacy and safety of netakimab compared with placebo in a pediatric population of subjects over 6 years of age with moderate to severe plaque psoriasis. The study will have randomized, double-blind, placebo-controlled study with open-arm comparison.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-10-11; most recent amendment 2026-05-22.
Status change: Recruiting → Active, Not Recruiting 2025-06-18
Trial Details
NCT Number NCT06640517
Lead Sponsor Biocad
Conditions Plaque Psoriasis
Enrollment 140 participants
Start Date 2024-08-08
Primary Completion 2026-06 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-27